SARS-CoV-2 扰乱临床研究：罕见病专项试验网络的作用。
SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network.
机构信息
CF Centre Cologne, Children's Hospital, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany
European Cystic Fibrosis Society, Karup, Denmark.
出版信息
Eur Respir J. 2020 Sep 17;56(3). doi: 10.1183/13993003.02114-2020. Print 2020 Sep.
Abstract
相似文献
1
SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network.SARS-CoV-2 扰乱临床研究：罕见病专项试验网络的作用。
Eur Respir J. 2020 Sep 17;56(3). doi: 10.1183/13993003.02114-2020. Print 2020 Sep.
2
Avoidable Waste of Research on Coronavirus Disease 2019 (COVID-19).2019冠状病毒病（COVID-19）研究中的可避免浪费
Obstet Gynecol. 2020 Jul;136(1):191. doi: 10.1097/AOG.0000000000003978.
3
Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".对《2019冠状病毒病（COVID-19）：对临床牙科护理的影响》的回复
J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
4
Temperature-dependent surface stability of SARS-CoV-2.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的温度依赖性表面稳定性
J Infect. 2020 Sep;81(3):452-482. doi: 10.1016/j.jinf.2020.05.074. Epub 2020 Jun 3.
5
Generalizability of Coronavirus Disease 2019 (COVID-19) Clinical Prediction Models.2019冠状病毒病（COVID-19）临床预测模型的可推广性
Clin Infect Dis. 2020 Jul 28;71(15):897. doi: 10.1093/cid/ciaa417.
6
Rhabdomyolysis as Potential Late Complication Associated with COVID-19.横纹肌溶解症作为与2019冠状病毒病相关的潜在晚期并发症
Emerg Infect Dis. 2020 Oct;26(10):2535. doi: 10.3201/eid2610.202225. Epub 2020 Jul 2.
7
Research Response to SARS-CoV-2/COVID-19.对严重急性呼吸综合征冠状病毒2/2019冠状病毒病的研究应对措施
Mayo Clin Proc. 2020 Sep;95(9S):S52-S55. doi: 10.1016/j.mayocp.2020.06.048. Epub 2020 Jul 7.
8
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.一名新冠肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):323-324. doi: 10.7326/L20-0894.
9
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.新型冠状病毒肺炎患者肺部的组织病理学变化及严重急性呼吸综合征冠状病毒2免疫染色
Ann Intern Med. 2020 Aug 18;173(4):324. doi: 10.7326/L20-0895.
10
Role of Serology in the Coronavirus Disease 2019 Pandemic.血清学在2019冠状病毒病大流行中的作用
Clin Infect Dis. 2020 Nov 5;71(8):1935-1936. doi: 10.1093/cid/ciaa510.
引用本文的文献
1
The impact of the COVID-19 pandemic and the changing landscape of CF on the cASPerCF trial: a real-world experience.COVID-19大流行及囊性纤维化（CF）格局变化对cASPerCF试验的影响：一项真实世界经验
Trials. 2024 Oct 2;25(1):645. doi: 10.1186/s13063-024-08510-1.
2
Adapting, restarting, and terminating a randomised control trial for people with cystic fibrosis: Reflections on the impact of the COVID-19 pandemic upon research in a clinical population.针对囊性纤维化患者调整、重启和终止一项随机对照试验：关于新冠疫情对临床人群研究影响的思考
Contemp Clin Trials Commun. 2024 Mar 27;39:101294. doi: 10.1016/j.conctc.2024.101294. eCollection 2024 Jun.
3
Neurofibromatosis: New Clinical Challenges in the Era of COVID-19.神经纤维瘤病：COVID-19时代的新临床挑战
Biomedicines. 2022 Apr 19;10(5):940. doi: 10.3390/biomedicines10050940.
4
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.欧洲囊性纤维化患者感染新型冠状病毒2后出现严重后果的因素。
ERJ Open Res. 2021 Dec 27;7(4). doi: 10.1183/23120541.00411-2021. eCollection 2021 Oct.
5
Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami.儿童非哮喘性慢性呼吸道疾病：新冠疫情海啸。
Ital J Pediatr. 2021 Nov 6;47(1):220. doi: 10.1186/s13052-021-01155-9.
6
A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis.囊性纤维化患者临床和家庭肺功能测定的纵向比较。
J Cyst Fibros. 2022 Jan;21(1):78-83. doi: 10.1016/j.jcf.2021.08.013. Epub 2021 Aug 31.
7
Protecting clinical trials in cystic fibrosis during the SARS-CoV-2 pandemic: risks and mitigation measures.保护 SARS-CoV-2 大流行期间囊性纤维化的临床试验：风险和缓解措施。
Trials. 2021 Aug 28;22(1):578. doi: 10.1186/s13063-021-05457-5.
8
Clinical Research Redirection and Optimization During a Pandemic.大流行期间的临床研究转向和优化。
Anesthesiol Clin. 2021 Jun;39(2):379-388. doi: 10.1016/j.anclin.2021.03.004.
9
Research and Management of Rare Diseases in the COVID-19 Pandemic Era: Challenges and Countermeasures.新冠疫情时代罕见病的研究与管理：挑战与对策
Front Public Health. 2021 Apr 15;9:640282. doi: 10.3389/fpubh.2021.640282. eCollection 2021.
10
JCF Year in Review.《JCF》年度回顾
J Cyst Fibros. 2021 Jan;20(1):1-2. doi: 10.1016/j.jcf.2021.01.004.
本文引用的文献
1
Preserving Clinical Trial Integrity During the Coronavirus Pandemic.在新冠疫情期间维护临床试验的完整性。
JAMA. 2020 Jun 2;323(21):2135-2136. doi: 10.1001/jama.2020.4689.
2
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease.CFTR 调节剂治疗对严重肺囊性纤维化患者结局的影响。
Eur Respir Rev. 2020 Mar 20;29(155). doi: 10.1183/16000617.0112-2019. Print 2020 Mar 31.
3
Disease-specific clinical trials networks: the example of cystic fibrosis.疾病特异性临床试验网络：以囊性纤维化为例。
Eur J Pediatr. 2016 Jun;175(6):817-24. doi: 10.1007/s00431-016-2712-z. Epub 2016 Mar 15.
Zotero 插件